Is Time Running Out for Merck?
A Federal Jury in New Orleans has ruled against Merck as the maker of Vioxx and ordered the company to pay $51 million to a retired FBI agent who suffered a heart attack after taking the drug. This post on the Wall Street Journal law blog raises the question of whether the passage of time favors Plaintiffs in mass tort litigation. I tend to agree with Texas trial lawyer, Mark Lanier, who is of the opinion that the passage of time helps develop information that erodes the base defense for companies like Merck.
